FUJISAWA IS JAPAN'S SEVENTH-LARGEST PHARMACEUTICAL COMPANY. IT SEL...
78. Fujisawa is Japan's seventh-largest pharmaceutical company. It sells drugs for organ transplant patients
to increase the probability the new organ will operate efficiently and not be rejected. Currently, the
only products Fujisawa makes are these organ transplant drugs, which it sells worldwide. Its patents
protect it from competitors. Fujisawa has a:
a. brand name advantage
b. niche competitive advantage
c. cost competitive advantage
d. marketing competitive advantage
e. complete competitive advantage
ANS: B
A niche competitive advantage is the advantage achieved when a firm seeks to target and effectively
serve a small segment of the market, in this case people who need organ transplant drugs.
PTS: 1
REF: 35-36
OBJ: 02-6
TOP: AACSB Reflective Thinking
KEY: CB&E Model Strategy
MSC: BLOOMS Level III Application